Diagnosis and treatment of the overactive bladder syndrome

University Medical Center Utrecht, The Netherlands
International Congress Series 04/2005; 1279:413-417. DOI: 10.1016/j.ics.2004.12.045


In recent years, the overactive bladder syndrome in women has become an important issue in clinical practice. International consensus about the definition, diagnostic work-up and treatment options will lead to a better understanding of the problem and will eventually be of benefit for the patients. In this review, current practice regarding diagnostic procedures and treatment are discussed.

8 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The refractory overactive bladder patient is a complex new entity for the urologic community. We present the most current review of this difficult subject matter with an emphasis on evaluation and new treatment options such as sacral neuromodulation and botulinum toxin injection. It is hoped that in this new era of medical innovation, extirpation and reconstruction of the bladder will become historic in nature and refractory therapy can be transitioned to the office and outpatient operation rooms.
    No preview · Article · Oct 2006 · Current Urology Reports
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nocturia may be attributable to nocturnal polyuria (nocturnal urine overproduction), a diminished nocturnal bladder capacity or a combination of the two conditions. A disorder of the vasopressin (antidiuretic hormone) system with very low or undetectable levels of vasopressin at night, affecting some elderly people, may cause an increase in the nocturnal urine output, which in the most extreme cases accounts for 85% of the 24-hour diuresis. The increased urine output can be treated with desmopressin orally at bedtime, generally using low doses. Self-imposed fluid restrictions before bedtime are not effective in reducing the nocturnal urine output in this condition. Nocturia is also more prevalent in association with a reduced bladder capacity. Antimuscarinic drugs are used in attempts to depress involuntary bladder contractions. Decreased nocturnal voided volumes in men and consequent increased nocturia may suggest difficulty in emptying the bladder or detrusor overactivity. α1-Adrenoceptor antagonists and 5α-reductase inhibitors are often used in men with symptoms indicative of benign prostatic hyperplasia, and one of their effects is reduction of nocturia. In women, estrogen deficiency, a common consequence of the menopausal transition, causes atrophic changes within the urogenital tract. Consequently, such women are more disposed to having urogenital symptoms, among them nocturia. This review emphasises the importance of correctly diagnosing and treating nocturia in elderly patients. This will improve patients’ sleep and, in turn, reduce their risk of fall injuries and the associated detrimental consequences, thereby improving patients’ health and quality of life.
    No preview · Article · Feb 2007 · Drugs & Aging
  • [Show abstract] [Hide abstract]
    ABSTRACT: The original purpose of pelvic floor exercises was to restore tone and function to the atrophied pelvic muscles with the rationale that this helps control involuntary loss of urine with physical activity such as coughing, sneezing, or laughing. The aim of pelvic floor muscle exercises in the treatment of overactive bladder is to inhibit involuntary detrusor contractions. Although their efficacy in the treatment of stress urinary incontinence has been well established and understood, the use of pelvic floor muscle exercises to inhibit detrusor contractions has not been well studied. This article reviews the literature pertaining to the role of pelvic floor muscle exercises in the treatment of overactive bladder symptoms.
    No preview · Article · Jun 2008 · Current Bladder Dysfunction Reports
Show more